These findings advance our understanding of EPHA1 signaling mechanisms and support the notion that alterations in EPHA1 signaling due to missense mutations contribute to Alzheimer’s disease pathogenesis. This evidence concerns the gene EPHA1 and early-onset autosomal dominant Alzheimer disease.